GlassScriptPhysician profile
Ryan M Turpen
NPI 1609957042
$12,545.51
in general payments reported to CMS, 2019-2025
47 companies · $2,989 in 2025
The $2,989 reported for 2025 was more than what 86% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,606 · 2020: $788 · 2021: $1,108 · 2022: $822 · 2023: $1,313 · 2024: $2,919 · 2025: $2,989.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,410 · Travel and Lodging: $2,643 · Education: $168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,409.72 |
| Travel and Lodging | $2,643.02 |
| Education | $167.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,870.17 | 2023-2024 | Aquabeam System, Aquabeam Robotic System |
| Boston Scientific Corporation | $1,591.90 | 2019-2025 | Lumenis Pulse 120h, Moses, Contour Vl |
| Neotract INC. | $1,565.83 | 2019-2020 | |
| Astellas Pharma US INC | $1,371.43 | 2019-2025 | Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $691.93 | 2019-2025 | Erleada |
| Antares Pharma, INC. | $516.01 | 2021-2025 | Xyosted, Nocdurna, Tlando |
| Axonics, INC. | $509.00 | 2020-2024 | Axonics, Bulkamid |
| Bayer Healthcare Pharmaceuticals INC. | $476.90 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $421.43 | 2019-2024 | Xiaflex, Aveed |
| Dendreon Pharmaceuticals LLC | $334.71 | 2019-2025 | Provenge |
| Pfizer INC. | $314.01 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $296.99 | 2023-2025 | Gemtesa, Orgovyx |
| Myriad Genetic Laboratories, INC. | $294.87 | 2020-2025 | Prolaris, Myrisk |
| Teleflex LLC | $227.35 | 2021-2025 | Urolift |
| C. R. Bard, INC. & Subsidiaries | $165.64 | 2019-2021 |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $162.47 | 2021-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Novartis Pharmaceuticals Corporation | $159.00 | 2024-2025 | |
| Angiodynamics, INC. | $128.20 | 2024-2025 | Nanoknife |
| Halozyme INC | $114.66 | 2023 | |
| Myovant Sciences INC. | $108.20 | 2021 | |
| Amgen INC. | $104.22 | 2019-2020 | |
| Coloplast Corp | $102.07 | 2019-2025 | |
| Urogen Pharma, INC. | $91.74 | 2022-2025 | |
| Olympus America INC. | $88.85 | 2025 | Itind System |
| Medtronic, INC. | $77.95 | 2021-2025 | Interstim, Endo Gia Ultra |
| Bioprotect Medical, INC. | $74.63 | 2025 | Bioprotect Balloon Implant System |
| Tempus Ai, INC | $57.67 | 2024 | |
| Medtronic USA, INC. | $55.42 | 2019-2020 | |
| Tolmar Pharmaceuticals, INC. | $55.39 | 2019-2020 | |
| Endo USA, INC. | $47.70 | 2024 | Xiaflex |
| Takeda Pharmaceuticals U.S.A., INC. | $45.28 | 2021 | |
| Ferring Pharmaceuticals INC. | $44.97 | 2025 | Adstiladrin |
| Convatec INC. | $43.77 | 2024 | |
| 180 Medical, INC. | $42.94 | 2023 | |
| Dentsply Ih INC. | $42.34 | 2019 | |
| Blue Earth Diagnostics | $41.30 | 2022 | |
| Immunitybio, INC. | $35.48 | 2024-2025 | |
| Healthtronics Stone Solutions, LLC | $25.15 | 2025 | Dornier Medtech, Dornier Medtech, Cvac Aspiration System |
| Telix Pharmaceuticals | $23.59 | 2025 | Illuccix |
| Agiliti Surgical, INC. | $22.14 | 2025 | Koelis Trinity Mri/US Fusion |
| Biotissue Holdings INC. | $19.79 | 2025 | |
| Accord Healthcare, INC. | $17.27 | 2023 | |
| Travere Therapeutics, INC. | $14.42 | 2020 | |
| Siemens Medical Solutions USA, INC. | $14.23 | 2024 | Uroskop Omnia Max |
| Abbvie INC. | $13.36 | 2019 | |
| Urovant Sciences INC | $11.59 | 2021 | |
| Ironwood Pharmaceuticals, INC | $11.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Turpen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.